Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DB25FPNTK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $86,621
Award facts
- Contract value 100% obligated
- $86,621.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, valued at $86,621.10. The contract, awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant role in federal medical procurement through the DLA Medical Supply Chain. The company's federal contract portfolio demonstrates extensive capabilities in supplying brand-name and generic pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This award reflects the company's competitive capability to meet federal procurement requirements, as evidenced by its history of non-set-aside, competitively awarded contracts ranging from modest to substantial values. The DLA Troop Support is concurrently planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among key strategic suppliers for Department of Defense healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FPNTK?
SPE2DB25FPNTK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FPNTK worth?
The government has obligated $86,621 on SPE2DB25FPNTK.
Is contract SPE2DB25FPNTK an order under another contract?
Yes. SPE2DB25FPNTK is a delivery order under SPE2DB20D2001, an indefinite delivery contract.
Was contract SPE2DB25FPNTK competed?
The extent of competition for SPE2DB25FPNTK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award